Updating and tendencies of bioavailability (BA) and bioequivalence (BE), regulatory aspects in Uruguay and the Latin American region.
- At: 2005 FIP Congress in Cairo (Egypt)
- Type: Poster
- By: DIAZ, Washington (DNSFFAA, DROGUERIA, Montevideo, Uruguay)
- Co-author(s): Ricca, Mariela (DNSFFAA, MONTEVIDEO, Uruguay)
The use of Generics, the responsibility assumed at the time of interchanging medicines with the efficiency and safety which must be given to the patient in his treatment, lead to necessity of having regulations according to the reality of the country and the International Norms. OBJETIVES: * Revision of the regulatory aspects of BA and BE of.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.